To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
29 Current news
rss
Roche: Japan approves breakthrough breast cancer drug
05-04-2001
management today. This is a strong example of Roche’s Integrated Health Care Solution’s concept, as a focused diagnostic helps doctors select the right patients to treat with Herceptin. Herceptin...
Roche: Valcyte receives US approval for treatment of AIDS-related CMV retinitis
Oral drug with IV potency
03-04-2001
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte (valganciclovir) for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. Valcyte...
MorphoSys Reports Year End 2000 Financial Results
21-03-2001
: - Conclusion of eight collaborations with companies including Centocor/Johnson&Johnson, Hoffmann-La Roche and BioGen - Achievement of four milestones in existing collaborations with GPC Biotech, Hoffmann-La...
Roche submits oral flu drug Tamiflu for regulatory approval in Europe
01-03-2001
Roche and Gilead Sciences, Inc. announced today that Roche has submitted Tamiflu (oseltamivir phosphate), the first oral neuraminidase inhibitor, to the European authorities (CPMP) for regulatory...
Roche and Prionics announce collaboration in the field of BSE tests
25-01-2001
Roche Diagnostics, a Division of the Roche Group, and Prionics Inc., a Zürich-based biotechnology company, today agreed on a collaboration that will respond to the increasing demand throughout Europe...
Franz B. Humer elected Chairman of the Board of Directors of Roche
14-12-2000
At its December meeting, the Board of Directors of Roche Holding elected Franz B. Humer as its new Chairman, effective 4 April 2001, i.e. following next year's Annual General Meeting of Shareholders...
Inauguration of new Roche Pharma Research building in Basel
06-12-2000
On 5 December, after a construction phase lasting two years, Roche has inaugurated the new Pharma Research Building designed by the Basel architects Herzog & de Meuron. Planning and construction...
Roche granted new Tamiflu indication for the prevention of influenza in the U.S.
20-11-2000
Roche and Gilead Sciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for a prevention indication for its influenza antiviral Tamiflu...
New Genotyping Tool Developed by Roche Expected to Speed Practical Applications of Genomic Research
16-11-2000
key genetic variations that contribute to human disease susceptibility. In a move designed to support this effort, Roche Bioscience today announced the successful validation of a novel mouse genotyping...
Netmeeting
